Common heart drug could stop deadly skin cancer spread
NCT ID NCT06157099
Summary
This study is testing whether atorvastatin, a medication commonly used to lower cholesterol, can prevent melanoma skin cancer from spreading to other parts of the body after it has been surgically removed. The trial involves 150 adults who have had high-risk melanoma surgically removed but are at risk of the cancer returning. Participants will take either atorvastatin or a placebo pill daily for up to five years to see if the drug reduces cancer recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.